Itamar Medical Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.01 |
Market Cap |
$108.48 M |
Shares Outstanding |
259.58 M |
Public Float |
- |
Address |
9 Halamish Street Caesarea HA 38900 Israel |
Employees | - |
Website | http://www.itamar-medical.com |
Updated | 07/08/2019 |
Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. The firm develops and markets two products, namely, WatchPAT and EndoPAT. The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. |